{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:08:31Z","timestamp":1764828511026},"reference-count":24,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.3892\/etm.2015.2602","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T08:18:12Z","timestamp":1435565892000},"page":"889-894","source":"Crossref","is-referenced-by-count":5,"title":["Augmented anti-angiogenesis activity of polysulfated heparin-endostatin and polyethylene glycol-endostatin in alkali burn-induced corneal ulcers in rabbits"],"prefix":"10.3892","volume":"10","author":[{"given":"ZHAO-NA","family":"LI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHONG-FANG","family":"YUAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUO-YING","family":"MU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MING","family":"HU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LI-JUN","family":"CAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YA-LI","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MING-XU","family":"GE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,6,29]]},"reference":[{"key":"key20180108123900_b1-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: An endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"key":"key20180108123900_b2-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2121-6-38","article-title":"The response of VEGF-stimulated endothelial cells to angiostatic molecules is substrate-dependent","volume":"6","author":"Addison","year":"2005","journal-title":"BMC Cell Biol"},{"key":"key20180108123900_b3-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/104303403766682250","article-title":"Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells","volume":"14","author":"Dkhissi","year":"2003","journal-title":"Hum Gene Ther"},{"key":"key20180108123900_b4-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11373-007-9153-7","article-title":"Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model","volume":"14","author":"Lai","year":"2007","journal-title":"J Biomed Sci"},{"key":"key20180108123900_b5-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)61697-5","article-title":"Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin","volume":"159","author":"Mori","year":"2001","journal-title":"Am J Pathol"},{"key":"key20180108123900_b6-etm-0-0-2602","first-page":"138","article-title":"Randomized phase II trial on escalated doses of rh-endostatin (YH-16) for advanced non-small cell lung cancer","volume":"28","author":"Yang","year":"2006","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"key20180108123900_b7-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/path.2760","article-title":"Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells","volume":"222","author":"Zhuo","year":"2010","journal-title":"J Pathol"},{"key":"key20180108123900_b8-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drup.2005.03.001","article-title":"Endostatin: The logic of antiangiogenic therapy","volume":"8","author":"Abdollahi","year":"2005","journal-title":"Drug Resist Updat"},{"key":"key20180108123900_b9-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.3390\/ijms12042650","article-title":"In vivo anti-tumor activity of polypeptide HM-3 modified by different polyethylene glycols (PEG)","volume":"12","author":"Liu","year":"2011","journal-title":"Int J Mol Sci"},{"key":"key20180108123900_b10-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.biopha.2011.04.007","article-title":"Enhanced anti-angiogenesis and anti-tumor activity of endostatin by chemical modification with polyethylene glycol and low molecular weight heparin","volume":"66","author":"Tan","year":"2012","journal-title":"Biomed Pharmacother"},{"key":"key20180108123900_b11-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/jb\/mvn060","article-title":"Characterization and secondary structure analysis of endostatin covalently modified by polyethylene glycol and low molecular weight heparin","volume":"144","author":"Tan","year":"2008","journal-title":"J Biochem"},{"key":"key20180108123900_b12-etm-0-0-2602","first-page":"622","article-title":"Preparation, characterization and anti-angiogenesis activity of endostatin covalently modified by polysulfated heparin","volume":"67","author":"Ning","year":"2012","journal-title":"Pharmazie"},{"key":"key20180108123900_b13-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/abio.1997.2405","article-title":"Comparison of results of various methods used to determine the extent of modification of methoxy polyethylene glycol 5000-modified bovine cupri-zinc superoxide dismutase","volume":"254","author":"Bullock","year":"1997","journal-title":"Anal Biochem"},{"key":"key20180108123900_b14-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/aps.2011.17","article-title":"Epigallocatechin-3-gallate regulates cell growth, cell cycle and phosphorylated nuclear factor-\u03baB in human dermal fibroblasts","volume":"32","author":"Han","year":"2011","journal-title":"Acta Pharmacol Sin"},{"key":"key20180108123900_b15-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/aps.2011.7","article-title":"Novel liver-specific cholic acid-cytarabine conjugates with potent antitumor activities: Synthesis and biological characterization","volume":"32","author":"Chen","year":"2011","journal-title":"Acta Pharmacol Sin"},{"key":"key20180108123900_b16-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3748\/wjg.v10.i10.1409","article-title":"Effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenoviruses on antiangiogenesis","volume":"10","author":"Pan","year":"2004","journal-title":"World J Gastroenterol"},{"key":"key20180108123900_b17-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/hum.2009.153","article-title":"Adeno-associated vector (type 8)-mediated expression of soluble Flt-1 efficiently inhibits neovascularization in a murine choroidal neovascularization model","volume":"21","author":"Igarashi","year":"2010","journal-title":"Hum Gene Ther"},{"key":"key20180108123900_b18-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1166\/jnn.2010.1812","article-title":"Tumor targeting of protein through poly (ethylene glycol) conjugation with metal coordination","volume":"10","author":"Yoshida","year":"2010","journal-title":"J Nanosci Nanotechnol"},{"key":"key20180108123900_b19-etm-0-0-2602","first-page":"44","article-title":"Effects of AMD3100 subconjunctival injection on alkali burn induced corneal neovascularization in mice","volume":"4","author":"Peng","year":"2011","journal-title":"Int J Ophthalmol"},{"key":"key20180108123900_b20-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"7138","DOI":"10.1200\/jco.2005.23.16_suppl.7138","article-title":"Results of phase III trial of rh-endostatin (YH-16) in advanced nonsmall cell lung cancer (NSCLC) patients","volume":"23","author":"Sun","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180108123900_b21-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.yexcr.2005.11.015","article-title":"Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action","volume":"312","author":"Folkman","year":"2006","journal-title":"Exp Cell Res"},{"key":"key20180108123900_b22-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0168-3659(01)00420-5","article-title":"Poly (ethylene glycol)-human serum albumin-paclitaxel conjugates: Preparation, characterization and pharmacokinetics","volume":"76","author":"Dosio","year":"2001","journal-title":"J Control Release"},{"key":"key20180108123900_b23-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/jb\/mvq070","article-title":"Site-specific modification of anti-angiogenesis peptide HM-3 by polyethylene glycol molecular weight of 20 kDa","volume":"148","author":"Zhu","year":"2010","journal-title":"J Biochem"},{"key":"key20180108123900_b24-etm-0-0-2602","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0463.2006.apm_235.x","article-title":"Low-molecular-weight heparins and angiogenesis","volume":"114","author":"Norrby","year":"2006","journal-title":"APMIS"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2015.2602\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T16:53:52Z","timestamp":1515430432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2015.2602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,29]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,6,29]]},"published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.3892\/etm.2015.2602"],"URL":"https:\/\/doi.org\/10.3892\/etm.2015.2602","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,29]]}}}